Current Biology
Research PaperTumor spectrum analysis in p53-mutant mice
Section snippets
Background:
The p53 tumor suppressor gene appears to be a critical regulator of normal cell proliferation. This is indicated by the fact that mutant alleles of this gene are found in a majority of human tumors, involving a wide range of tumor types [1]. In addition to the frequent somatic mutation of p53 in sporadic cancer, germline mutation of one allele of this gene in humans causes an inborn predisposition to cancer known as Li-Fraumeni syndrome [2]. Individuals with Li-Fraumeni syndrome are highly
p53 gene targeting
One allele of the p53 gene was disrupted in D3 ES cells using the targeting vector p53KO shown in Figure 1. The neomycin resistance gene (neo) in this vector is flanked by fragments of p53 totaling 8 kilobases (kb); neo replaces approximately 40 % of the p53 coding sequences, beginning within exon 2 (upstream of the initiator codon AUG) and extending into intron 6. The HSV-TK gene follows the p53 sequences to allow negative selection using the protocol of Mansour et al.[18]. p53KO was
Discussion
The method of gene targeting in mouse ES cells [24] has allowed the construction of a large number of novel mouse strains that can be used to study diverse areas of biology, including development, immunology, human genetic disease and cancer. Here, we have described the properties of a mouse strain carrying a targeted deletion mutation in the p53 tumor suppressor gene. Given the importance of p53 mutations in sporadic and familial forms of cancer, this strain and analogous strains constructed
Gene targeting
p53KO was constructed by cloning fragments of the murine p53 gene (isolated from strain BALB/c) [32] into the targeting vector pPNT [33]. The neo gene in p53KO is flanked by a 3.5 kb fragment extending from the Bam HI site in intron 1 to the NcoI in exon 2 and a 5 kb fragment extending from the Bam HI in intron 6 to the Eco RI downstream of exon 11 [32]. Electroporation of p53KO into D3 ES cells [34], subsequent drug selection, and Southern blot analysis were performed as described [28]. The
Acknowledgements
The authors wish to thank P. Hinds, A. Fazeli, P. Mombaerts, K. MacLeod, L. Johnson and S. Lowe for helpful discussion and advice; R. Hynes and J. Rossant for the gift of D3 ES cells; E. Harlow for the gift of antibodies PAb248 and M73; C. Crawford and J. Williams for technical assistance; and M. Weigel for help with preparation of the manuscript. T.J. is a Lucille P. Markey Scholar and this work was funded in part by a grant from the General Cinemas Charitable Trust. R.A.W. is supported in
Tyler Jacks (corresponding author), Lee Remington, Bart O. Williams and Earlene M. Schmitt, Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 USA.
Schlomit Halachmi, Dana-Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts 02215 USA.
Roderick T. Bronson, Department of Pathology, Tufts University Schools of Medicine and Veterinary Medicine, Boston, Massachusetts 02111 USA.
Robert A. Weinberg, Whitehead Institute
References (37)
p53 and the Li-Fraumeni syndrome
Cancer Genet Cytogenet
(1993)- et al.
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia telangiectasia
Cell
(1992) - et al.
Wild-type p53 restores cell-cycle control and inhibits gene amplification in cells with mutant p53 alleles
Cell
(1992) - et al.
Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
Cell
(1992) - et al.
Reconstitution of p53 expression in a non-producer Ab-MuLV-transformed cell line by transfection of a functional p53 gene
Cell
(1984) - et al.
p53-dependent apoptosis modulates the cytoxicity of anticancer agents
Cell
(1993) - et al.
Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene
Cell
(1991) - et al.
p53 mutations in human cancers
Science
(1991) - et al.
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms
Science
(1990) - et al.
Participation of p53 protein in the cellular response to DNA damage
Cancer Res
(1991)
Thymocyte apoptosis induced by p53-dependent and independent pathways
Nature
p53 is required for radiation-induced apoptosis in mouse thymocytes
Nature
Identification of p53 as a sequence-specific DNA binding protein
Science
The p53-mdm-2 autoregulatory feedback loop
Genes Dev
Wild-type p53 activates transcription in vitro
Nature
Oncogenic forms of p53 inhibit p53-regulated gene expression
Science
Wild-type p53 binds to the TATA-binding protein and represses transcription
Proc Natl Acad Sci USA
Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element
Genes Dev
Cited by (1780)
Immortalised murine R349P desmin knock-in myotubes exhibit a reduced proton leak and decreased ADP/ATP translocase levels in purified mitochondria
2024, European Journal of Cell BiologyNEF-Induced HIV-Associated Nephropathy Through HCK/LYN Tyrosine Kinases
2023, American Journal of Pathology
Tyler Jacks (corresponding author), Lee Remington, Bart O. Williams and Earlene M. Schmitt, Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 USA.
Schlomit Halachmi, Dana-Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts 02215 USA.
Roderick T. Bronson, Department of Pathology, Tufts University Schools of Medicine and Veterinary Medicine, Boston, Massachusetts 02111 USA.
Robert A. Weinberg, Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142 USA.